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Cleared by a Th1 Immune Response
Vitomir Djokic†, Lavoisier Akoolo† and Nikhat Parveen*
Department of Microbiology, Biochemistry and Molecular Genetics, Rutgers New Jersey Medical School, Newark, NJ,
United States
Babesia microti is a malaria-like parasite, which infects ∼2000 people annually, such
that babesiosis is now a notifiable disease in the United States. Immunocompetent
individuals often remain asymptomatic and are tested only after they feel ill. Susceptible
C3H/HeJ mice show several human-like disease manifestations and are ideal to study
pathogenesis of Babesia species. In this study, we examined parasitemia of B. microti at
different time points and assessed its impact on hemoglobin levels in blood, on spleen
pathology and overall immune response in C3H/HeJ mice. Peak parasitemia of 42.5%
was immediately followed by diminished hemoglobin level. Parasitemia at 21 days of
infection was barely detectable by microscopy presented 5.7 × 108 to 5.9 × 109
B. microti DNA copies confirming the sensitivity of our qPCR. We hypothesize that
qPCR detects DNA released from recently lysed parasites or from extracellular B. microti
in blood, which are not easily detected in blood smears and might result in under-
diagnosis of babesiosis in patients. Splenectomized patients have been reported to
show increased babesiosis severity and result in high morbidity and mortality. These
results emphasize the importance of splenic immunity in resolution of B. microti infection.
Splenomegaly in infected mice associated with destruction of marginal zone with lysed
erythrocytes and released B. microti life forms in our experiments support this premise.
At conclusion of the experiment at 21 days post-infection, significant splenic B and T
cells depletion and increase in macrophages levels were observed in B. microti infected
mice suggesting a role of macrophage in disease resolution. Infected mice also showed
significantly higher plasmatic concentration of CD4 Th1 cells secreted cytokines such
as IL-2 and IFN-γ while cytokines such as IL-4, IL-5, and IL-13 secreted by Th2 cells
increase was not always significant. Thus, Th1 cells-mediated immunity appears to be
important in clearance of this intracellular pathogen. Significant increase in IL-6 that
promotes differentiation of Th17 cells was observed but it resulted in only moderate
change in IL-17A, IL-17F, IL-21, and IL-22, all secreted by Th17 cells. A similar immune
response to Trypanosoma infection has been reported to influence the clearance of this
protozoan, and co-infecting pathogen(s).
Keywords: Babesia microti, protozoan pathogenesis, babesiosis, tick-borne infection, immunosuppression,
blood-borne pathogen
Abbreviations: FISH, fluorescence in situ hybridization; IFA, indirect immunofluorescence assay; qPCR, real-time
quantitative polymerase chain reaction; TTB, transfusion transmitted babesiosis.
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INTRODUCTION
Tick-borne diseases have been increasing steadily in the last two
decades in North America and Europe that include bacterial, viral
and parasitic pathogens. Transmission of multiple pathogens
by a single tick bite has been reported to occur (Dunn et al.,
2014; Rizzoli et al., 2014; Moutailler et al., 2016). Babesia species
are tick-transmitted parasites with the most cases of babesiosis
attributed to Babesia microti in the United States, with some
patients show infection with B. duncani in Western states,
while B. divergens is primarily responsible for babesiosis in
Europe (Centers for Disease Control and Prevention, 2012).
Approximately 2000 cases of babesiosis occur in the United States
every year, which resulted in its declaration as a notifiable
disease by CDC in 2011. B. microti infection affects the
Northeastern United States; Connecticut, Massachusetts, New
Jersey, New York, and Rhode Island along with the Midwestern
states of Wisconsin and Minnesota (Knapp and Rice, 2015).
Together they represented 94% of babesiosis cases in the
United States in 2014.
Babesia species are intracellular parasites of red blood cells
(RBCs), where they multiply until erythrocytes burst. Clinical
disease ranges from asymptomatic or mild flu-like symptoms
in immunocompetent people, including fever and myalgia, to
acute or sometimes fatal disease in immunocompromised or
splenectomized individuals (Genda et al., 2016). Patients are
often tested for babesiosis only after observation of hemolytic
anemia. Babesia species can also transmit through transplacental
route and can cause jaundice, anemia and neutropenia in
children (Joseph et al., 2011, 2012; Luckett et al., 2014).
Immunocompetent individuals can establish Babesia carriage
state without any clinical manifestations for long periods of
time. Due to survival of these parasites during cold storage,
infected donated whole blood and blood products can cause
blood transfusion transmitted babesiosis (TTB) that have severe
consequences in the immunocompromised patients (Herman
et al., 2010; Herwaldt et al., 2011; Sinski et al., 2011; Cushing and
Shaz, 2012; Cursino-Santos et al., 2014; Fang and McCullough,
2016). Babesiosis is the most prevalent transfusion transmitted
disease in the United States such that FDA has recently
recommended that blood donors should be screened for Babesia
infection (Lobo et al., 2013; United States Food and Drug
Administration, 2014).
Current confirmatory test for babesiosis is microscopic
examination of Giemsa-stained blood smears. However, this
method is time consuming and requires a specific expertise
for correct diagnosis because pleomorphic, non-synchronous
trophozoites and ring forms can make Babesia identification
difficult. This method is also very labor intensive. Therefore, it
cannot be used for large scale testing of donated blood samples.
Some diagnostic laboratories employ FISH for diagnosis of
babesiosis that also requires microscopic examination. Serologic
tests are more sensitive and efficient; however, these tests cannot
detect acute disease before the adaptive immune response is
established and are also unable to distinguish active disease
from the past infections or reinfections, thus, creating a
major diagnostic problem particularly in the endemic regions
(Magnarelli et al., 1998; Foppa et al., 2002; Hunfeld et al., 2002;
Yoshinari et al., 2003; Fox et al., 2006; Vannier et al., 2008;
Lempereur et al., 2015; Mayne, 2015; Wormser et al., 2015).
Nucleic Acid Tests have been used for examination of both
humans and ticks and have more promise for diagnosis of
babesiosis including blood donors (Bose et al., 1995; Krause et al.,
1996a; Cushing and Shaz, 2012; Michelet et al., 2014; Jahfari
et al., 2016). We found that our, molecular beacon probes based
real-time quantitative Polymerase Chain Reaction (qPCR) test,
identifies patient samples with babesiosis with greater sensitivity,
in a tick-borne diseases endemic state, New Jersey.
White footed mouse is natural reservoir of B. microti
in the United States. Susceptible C3H mice show several
manifestations like humans and offer ideal animal model
system to investigate pathogenesis of this protozoan parasite
(Ruebush and Hanson, 1979). Observation of pronounced
splenomegaly in B. microti infected C3H/HeN mice as well as
higher parasitemia levels and delayed clearance of B. microti
from blood stream of splenectomized mice indicate importance
of spleen immunity in resolution of babesiosis even in mice
(Coleman et al., 2005). B. microti parasitemia also reduced in
Severe Combined Immunodeficient (SCID) mice by adoptive
transfer of splenocytes from naïve immunocompetent mice,
further emphasizing the role of adaptive immune response
facilitated by splenic cells (Vannier et al., 2004). However,
a systematic study to assess the consequence of B. microti
infection on mice together with both plasmatic and splenic
immunity has not been carried out until now. Therefore,
B. microti pathogenesis and immunological response to
this intraerythrocytic pathogen remain poorly understood.
Involvement of innate immunity determined by macrophage
during B. microti infection was suggested to play the primary
role in babesiosis resistance in mice (Aguilar-Delfin et al.,
2001; Terkawi et al., 2015). Adoptive transfer of primed T
cells was reported to control mice reinfection by B. microti
likely due to also simulating primed B cell response (Meeusen
et al., 1985). Furthermore, CD4 and not CD8 cells were
shown to participate in elimination of B. microti in mouse
infection model (Hanafusa et al., 1998; Igarashi et al., 1999;
Hemmer et al., 2000a). Interestingly, human Babesia WA1
parasites infection in mice resulted in upregulation of both
TNFα and IFNγ resulting in severe pathogenesis and fatal
disease (Hemmer et al., 2000b). Surprisingly, anti-IFNγ
monoclonal antibodies partially reduced protection of mice
immune against B. microti and IFNγ-deficient mice did not
offer any protection against B. microti infection (Igarashi et al.,
1999).
We followed the multiplication cycle of B. microti in blood of
C3H/HeJ mice and assessed the impact of parasitemia increase
on hemoglobin levels in blood, on spleen pathology and on
overall splenic and plasmatic immune response. Our studies
demonstrate that innate immune response particularly due
to macrophage participation and adaptive immune response
triggered by stimulation of CD4 cells play critical roles in
elimination of parasitized erythrocytes during infection of mice
with B. microti. Furthermore, we also describe potential reason
for under detection of B. microti during human infection.
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MATERIALS AND METHODS
Human Samples
Blood samples from 133 patients collected in 2015 from three
different counties in New Jersey as described previously were
used in this study (Akoolo et al., 2017). Patients presenting
different clinical symptoms were recommended for testing for
tick borne diseases for initial evaluation, or follow-up care.
IGeneX tested air-dried blood smears for babesiosis by FISH
using 18S rDNA/rRNA as target. Stony Brook Laboratory for
Lyme disease performed serological testing by Indirect IFA.
Blood testing for babesiosis was conducted by microscopic
examination of Giemsa-stained smears. Remnant, coded sample
aliquots (collected for their own testing) were provided for
another study to the corresponding author. Results of their
tests were provided in unidentifiable/anonymized manner
under corresponding author’s approved, exempt-Institutional
Review Board (e-IRB) protocol, Pro2013002634, approved by
Institutional Review Board of Rutgers New Jersey Medical
School.
B. microti Infection Cycle in C3H/HeJ
Mice
The Newark Institutional Animal Care and Use Committee
(IACUC) designated members reviewed and approved the
protocol number D-14011-A1 under which this study was
conducted at Rutgers University New Jersey Medical School
following guidelines of the Animal Welfare Act, The Institute
of Laboratory Animal Resources Guide for the Care and Use of
Laboratory Animals, and Public Health Service Policy. B. microti
(ATCC30221) was first propagated in SCID mice to obtain
inoculum for subsequent experiments because these parasites
adapted to a particular host allow manifestation of full spectrum
of pathogenesis of B. microti (Gumber et al., 2016). Ten 4 weeks
old C3H/HeJ mice were infected at a dose of 104 parasitized
RBCs/mouse. To determine parasitemia, 5–10 µl blood was
collected from each infected mouse by tail bleed to prepare blood
smears that were Giemsa-stained according to CLSI guidelines
(Garcia et al., 2000). On the day of infection experiment in
immunocompetent C3H/HeJ mice, blood was collected from
SCID animals and inoculum dose determined. Briefly, total
erythrocytes per milliliter of blood were determined using a
hemocytometer and parasitized RBCs counted in a total of 20–
50 fields at high magnification. Numbers of infected RBCs were
determined by multiplying percent parasitemia with the total
count of RBCs/ml of blood. The number of parasitized RBCs was
then adjusted to 105/ml in PBS and 100 µl suspension injected
in each mouse intraperitoneally such that infection dose of 104
infected erythrocytes per animal was used to infect 4 weeks old
C3H/HeJ mice. Five uninfected mice were included as controls
for all analyses.
Monitoring of Parasitemia in Blood of
Infected Mice
Blood smears from the infected mice were prepared, and
Giemsa stained. Blood smears were then examined to determine
parasitemia and thus, progression of B. microti infection
up to 21 days of infection. Blood hemoglobin levels were
determined using a commercial kit (Hemocue R© Hb 201+
analyzer, Sweden) according to the manufacturer’s instructions.
Mice were euthanized at 21 days post infection and evaluated
further for disease pathology. Before euthanasia, heparinized
blood was collected from each mouse by cardiac puncture
and then mice were euthanized. Plasma was recovered after
centrifugation for cytokine profile determination.
IFA to Detect B. microti in Blood and
Spleen
For paraffin embedded spleen sections, slides were immersed in
xylene two times for 10 min interval to remove paraffin and
was followed by immersion in 100% ethanol twice and then
immersion in 95, 70, and 50% ethanol for 5 min each. A final rinse
with water was followed by rehydration in PBS. Slide edges were
marked with hydrophobic marker and then IFA was conducted
as described previously using pooled patient sera from four
individuals that tested positive in our previous studies (Akoolo
et al., 2017). Staining with 2-(4-amidinophenyl)-1H-indole-6-
carboxamidine (DAPI) was included to stain nucleus with the
anti-human secondary antibody conjugated to Alexa fluor 488
(Molecular Probes).
Quantification of B. microti in Blood by
qPCR
DNA was isolated from mice blood using QIAamp Blood midi kit
(Qiagen). Duplex qPCR was conducted using different dilutions
of genomic using the primers and molecular beacon probe for
gene encoding Thiamine pyrophosphokinase (B. microti TPK)
as we described previously (Chan et al., 2013; Akoolo et al.,
2017). Amplification was performed in 25 µl reaction mixtures.
Based upon the genome size (6.5 Mb), of B. microti, 8 ng of
DNA was calculated to contain 106 copies of B. microti TPK
gene. A standard curve was prepared using 10-fold dilutions of
B. microti genomic DNA. Leukocytes from mouse blood were
used to amplify Nidogen gene as an internal control. Inclusion
of this control ensured that the quality of DNA was suitable for
PCR (Chan et al., 2013).
Isolation of and Characterization of
Splenocytes by Flow Cytometry
Aseptically harvested spleens from infected and uninfected
mice were imaged, weighed and single cell suspension of the
splenocytes prepared. Briefly, spleen was sliced into small pieces
and strained through a 70 µm nylon sterile cell strainer into
50 ml conical tube. After washing cells with Phosphate buffered
saline by centrifugation at 1,500 rpm, RBCs were lysed using
Ammonium-Chloride–Potassium lysis buffer (Thermo Fisher).
The splenocytes were then resuspended in FACS buffer at 106/ml
concentration and stained by labeling with respective marker
antibodies tagged with different fluorophores. For staining, the
cells were incubated for 30 min in the dark at 4◦C using the
fluorophores tagged antibodies; B cells with Brilliant violet 421
anti-mouse CD19 antibody (Biolegend), NK cells with APC-Cy7
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anti-mouse NK1.1 antibody (Bilegend), CD3 with PE-Cy7 anti-
mouse CD3 antibodies (Biolegend), and macrophages with anti-
mouse F4/80 Brilliant violet 605 antibody. The cells were washed
with PBS containing 2% FBS by centrifugation, and resuspended
in Fluorescence Activated Cell Sorting (FACS) buffer. Cells were
sorted using a flow cytometer BD LSRFortessaTM X-20 (BD
Biosciences) driven by software FACS DiVa (BD Biosciences).
Analysis of the acquired data was performed using software,
FlowJo, Version 10.3.
Determination of Plasmatic Cytokines
Changes in the Infected Mice
Heparinized blood samples were centrifuged and plasma
was collected. Major cytokines were detected and quantified
using commercial bead-based immunoassay kit LEGENDplexTM,
mouse multiplex cytokine panel (Biolegend) according to
manufacturer’s instructions with cytokines IFN-γ, TNF-α, IL-2,
IL-4, IL-5, IL-6, IL-10, IL-13, IL-17A, IL-17F, IL-21 and IL-22
analyzed. Briefly, all plasma samples were diluted in 1:1 in assay
buffer and all analyses were performed in duplicates for each
sample. Samples were treated according to Biolegned’s standard
protocol, washed using the filter plates, and then examined using
the BD LSRFortessaTM X-20 (BD Biosciences) driven by software
FACS DiVa (BD Biosciences). Calculations were performed using
Legendplex 7.1 application (Vigene Tech Inc.).
Statistical Analysis
All data collected was analyzed by GraphPad Prism 7.0a
(GraphPad Software). Results are presented as mean ± standard
deviation (S.D.). Comparisons were made between groups using
unpaired student two-tailed t-tests for unequal variance to
determine statistical significant difference between paired groups.
Thus, values below 0.05 were considered significant for a paired
group comparison at 95% confidence interval.
RESULTS
B. microti Infection Is Detected More
Efficiently by qPCR Than IFA, FISH, or
Blood Smear Microscopy
All patient samples were tested three times and are shown as
positive (+) or negative (−) for each test. Thus, (+++) depict
that assay was positive all three times while (+) indicates one
positive out of three repeats, likely due to low parasitemia. Out
of 133 human tested samples, qPCR detected 71 positive and
62 negatives. Seven samples were positive by both qPCR and
IFA, 16 by qPCR and FISH, and 15 by qPCR and microscopic
examination of Giemsa-stained blood smears (Figure 1). We
detected 21 qPCR positive samples that were negative by IFA,
five that were FISH negative, and four in which parasites-infected
erythrocytes were not detected by microscopy (Figure 1). Almost
all qPCR negative samples (60/62) were negative in other
diagnostic tests. Only two samples that were positive by IFA
and FISH produced negative qPCR results (Figure 1). Thus,
FIGURE 1 | Comparison of diagnostics by IFA, FISH and Microscopy for
babesiosis with qPCR using molecular beacon probes for BmTPK in human
blood samples. For all patients samples, qPCR was repeated three times and
results of each repeat are marked by ‘+’ or ‘–’ sign. Thus, +/+/+ indicates that
qPCR was positive in all three repeats of the qPCR for an individual sample.
There is a high correlation between all three tests when samples were
negative by qPCR. Higher sensitivity of detection of B. microti by qPCR is
demonstrated by a significant number of positive samples that were
diagnosed negative for babesiosis by Indirect IFA, FISH and microscopic
examination of Giemsa-stained blood smears.
our qPCR could detect B. microti presence in blood in a more
sensitive manner than other currently used tests.
Parasitemia Pattern in Mice Detected by
Microscopy
We inoculated ten C3H/HeJ mice with B. microti to study its
pathogenesis. Seven days after infection, 0.1% parasitemia was
obtained that steadily increased and culminated to its peak
level of average 42.5% on 13th day of infection (Figure 2A)
and then started declining. Increased B. microti parasitemia
was followed by depletion of RBCs and decreased hemoglobin.
One day after observed peak parasitemia, i.e., on day 14 of
infection, hemoglobin levels reached to the minimal levels of
3.3 g/dl. Hemolytic anemia is also a hallmark of symptomatic
babesiosis in humans. With subsequent decline in parasitemia,
hemoglobin levels started returning to normal values with the
value of 9.8 g/dl detected on 21st day post infection (Figure 2A).
At this time point, parasitemia was barely detectable (<0.03%)
by microscopic examination of Giemsa-stained blood smears.
We then performed qPCR to assess the presence of the parasitic
DNA in blood at this stage of infection because our qPCR was
found to be more sensitive in detection of B. microti presence
in the human blood (Figure 1). Our results with mouse samples
confirmed the sensitivity of the qPCR test because surprisingly,
high parasitic DNA copy numbers of 5.7 × 108 to 5.9 × 109
were detected in different infected mice at this stage (Figure 2B).
To identify cause of this discrepancy between two tests, and
determine whether persistence of B. microti DNA in blood
was responsible for our qPCR results, we further examined
blood smears more carefully and identified several B. microti
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FIGURE 2 | Course of B. microti infection and detection of parasites in blood
of susceptible C3H/HeJ mice. (A) Increase in parasitemia resulted in a
dramatic drop in hemoglobin levels reaching the lowest levels 1 day after peak
B. microti parasitemia was obtained. Recovery of hemoglobin was rapid after
decline in parasitemia. Parasitized erythrocytes were barely detectable by
microscopy on 21st day of infection. (B) High copy numbers of B. microti
DNA were present in blood of the infected animals at this stage of infection.
(C) Several extracellular, released parasites can be observed in Giemsa
stained blood smear of infected mice supporting our qPCR results.
(D) The presence of external, released green fluorescent B. microti (marked by
arrows) as well as intracellular parasites (marked by arrowheads) were
observed by IFA of the blood smears confirming Giemsa stained blood
smears results shown in (C).
structures outside the erythrocytes (Figures 2C,D). Detection of
these parasites explains release of parasites from lysed RBCs and
corroborates our qPCR results. It is possible that these released
parasites failed to infect RBCs due to significantly reduced levels
of mature erythrocytes in blood (Borggraefe et al., 2006; Skariah
et al., 2017). The lack of detection of B.microtiDNA in the control
mice was as expected (data not shown).
Effect of B. microti Infection on Spleen of
Mice
Spleen is considered to play an important role during babesiosis
in patients such that splenectomized patients show more severe
life-threatening disease. Systematic analysis of contribution of
spleen in babesiosis resolution in humans is not possible.
Therefore, we decided to study the impact of B. microti infection
on spleen of infected mice. Spleen sizes of B. microti infected
mice consistently increased, i.e., significantly higher than that
of the spleen sizes of the naïve mice, as described previously
(Coleman et al., 2005). Comparative sizes of infected and
naïve mice, five mice each, are shown (Figure 3A). Weights
of spleen correlated with their increased size in the infected
mice (average weight 0.743 g) as compared to naïve animals
average weight 0.08 g) and difference was statistically significant
(p < 0.0001, 95%CI). Histopathological examination of spleen
sections after Hematoxylin-Eosin staining showed depletion
of marginal zone in B. microti infected animals. In addition,
enlarged red and white pulps were observed in the spleens of the
infected mice such that these two zones were found interwoven
throughout the organ (Figure 3B). A careful examination
of spleen sections under high magnification also showed the
presence of lysed RBCs as well as extracellular B. microti life
forms (Figure 3B). The presence of the released, extracellular
parasites in spleen was further confirmed by IFA (Figure 3C).
Spleen and liver are the major organs of reticuloendothelial
system. This system plays a critical role in degradation of
defective erythrocytes and cleaning the blood impurities. In our
experiments, mouse spleen appears to play a role in clearance of
parasitized RBCs. It is possible that another organ of this system,
liver, could also play a role in removal of B. microti infected
RBCs.
Effect of B. microti Infection on Splenic
Immune Cells
We further examined whether there are changes in splenocytes
involved in immunity to allow clearance of infected RBCs.
Surprisingly, B. microti infected mice on day 21 post infection
showed difference in numbers of splenic B, T cells, and
macrophages in comparison with naïve animals. Total cell
count from each mouse for FACS analysis was adjusted to
100,000/per mouse. Significant depletion of both CD19+
B cells from an average of total 39,655 (39.6%) in naïve to
16,119 (16.3%) in B. microti infected mice, and from total
average 18,423 (18.42%) CD3+ T cells in control group to
10.1% in B. microti infected mice were observed consistently.
These observations indicate that B. microti infection causes
significant subversion of adaptive immune response determine
by spleen. Interestingly, macrophages (F4/80) levels were
higher with total average of 6,641 (6.6%) macrophage in mice
infected with B. microti as compared to an average of 1,892
(1.9%) in control animals. Splenic NK1.1 cells total count
and percentage remained unaffected after B. microti infection
20,781versus 20,615 (20.8% versus 20.6%), respectively. These
results indicate a major role of innate immune response in
clearance of parasites. Increase in splenic macrophage suggests
their contribution in clearance of parasitized erythrocytes
that reach spleen as an organ in reticuloendothelial system.
Although no changes in splenic NK1.1 cell percentage were
observed, their role in resolution of parasitemia cannot be ruled
out. Enlargement and dark color of spleen of B. microti
infected mice could be due to increased hematopoietic
support and increased macrophages activity resulting in
erythrophagocytosis.
Detection of Mouse Pro-inflammatory
Cytokines in Plasma
The cytokine superfamily of proteins is involved in the signaling
and communications between cells. They are fingerprints of the
immune response generated in response to infection, injury or
even cancer. Plasmatic cytokine profile is more important for
clearance of blood borne pathogens. Therefore, we decided to
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FIGURE 3 | Impact of B. microti infection on spleen of the infected mice. (A) B. microti infection resulted in a significant increase in spleen sizes of mice compared to
uninfected, naïve mice. (B) White and red pulp zones were significantly enlarged while demarcation zone was not apparent in the spleen of B. microti infected mice.
Numbers of lysed erythrocytes (marked by arrowheads) as well as various free parasitic forms (marked by arrows) were also observed in infected mouse spleen.
(C) In IFA conducted the spleen section, red color indicates auto-fluorescence of RBCs, blue shows nuclear staining of cells while green fluorescence marks
B. microti probed with infected human plasma followed by detection with Alexa fluor 488 conjugated secondary antibodies. Apparent lysed infected erythrocytes
presence is marked by a circle. Several free, released parasitic forms were also detected (marked by arrows) among erythrocytes. Bars represent 25 µm.
determine changes in immune response in blood by analysis of
plasmatic cytokines profile in response to B. microti infection. We
examined the levels of 13 cytokine levels in plasma of B. microti
infected versus uninfected mice. B. microti infection did not
affect level of IL-9 in mouse plasma (data not shown). IFN-γ,
TNF-α, IL-2, IL-4, IL-6, IL-10, IL-13, IL-17F, and IL-22, showed
significantly higher levels compared to naïve animals (Figure 4).
Highest differences were observed for IL-2 of B. microti infected
mice (99.7 pg/ml) compared to naïve animals (80.8 pg/ml)
(Figure 4A). B. microti infected mice also displayed higher
concentrations of TNF-α (95.2 pg/ml), IL-6 (119.8 pg/ml) and
IL-10 (207.1 pg/ml) which were all significantly higher than the
control group displaying concentrations of 81.8, 98.2, 107 pg/ml,
respectively (Figures 4B–D). IFN-γ, IL-4, IL-13, IL-17F, and
IL-22 in B. microti infected mice showed concentrations of
101.9, 118.9, 161.3, 99.7, 83.7 pg/ml, respectively, relative to the
naïve animals that showed concentrations of 88.8, 93.8, 143,
87, 66.4 pg/ml, respectively (Figures 4E–I). Difference between
IL-5, IL-17A, and IL-21 levels between B. microti infected and
uninfected mice were not significant (Figures 4J–L). Considering
cytokines have a short life, the changes in cytokine profile here
could represent an ongoing low level B. microti infection in mice
that could not be detected in blood smears but was detectable by
qPCR. Furthermore, a declining cytokine levels are likely detected
at this stage of infection such that potential higher levels of these
cytokines presence during peak parasitemia to allow parasite
clearance.
DISCUSSION
Babesia microti infection of humans has become very prominent
in the last decade, both in North America and Europe (Hersh
et al., 2014; Rizzoli et al., 2014; Knapp and Rice, 2015;
Diuk-Wasser et al., 2016). In majority of immunocompetent
individuals, infection remains unseen, with mild, flu-like
symptoms or diminished hemoglobin levels and anemia.
However, in combination with other tick-transmitted diseases
such as Borrelia burgdorferi even in healthy person this parasite
can intensify clinical disease and its severity (Krause et al., 1996b;
Knapp and Rice, 2015). Babesiosis has tremendous consequences
in the immunocompromised individuals and infants and can
even be fatal (Usmani-Brown et al., 2013; Menis et al., 2015;
Akoolo et al., 2017). Equally dangerous is newly identified
route of transmission of B. microti, via blood transfusion. In
these cases, immunocompetent donors are undiagnosed and
remain Babesia carriers such that blood recipients who are often
immunocompromized individuals can exhibit high morbidity
and mortality (Herwaldt et al., 2011; Cushing and Shaz, 2012; Kitt
et al., 2016).
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FIGURE 4 | Increased cytokine levels in mice after 21 days of infection. (A) Highest difference between B. microti infected and uninfected, naïve mice was observed
in concentration of IL-2 (99.7 pg/ml compared to 80 pg/ml, p < 0.0005). (B–D) Concentrations of TNF-α (95.2 pg/ml), IL-6 (119.8 pg/ml) and IL-10 (207.1 pg/ml)
were significantly higher in infected mice relative to control group (p < 0.005, <0.01, <0.01, respectively). (E–I) IFN-γ, IL-4, IL-13, IL-17F, and IL-22 of B. microti
infected mice, showed modest but statistically significant increase in infected mice plasma relative to the naïve animals (p < 0.05 each; 95% CI).
(J–L) Concentrations of IL-5, IL-17A, and IL-21 were not significantly different between infected and uninfected mice. Comparisons were made between groups
using unpaired student two-tailed t-tests for unequal variance at 95% Confidence Interval (CI) (∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005).
Several diagnostic tests are available for diagnosis of
babesiosis; however, blood smear test is still considered gold
standard by CDC and WHO (Clinical and Laboratory Standards
Institute, 2000; Akoolo et al., 2017). One reason is that antibodies
can persist even more than a year after the clearance of
Babesia infection (Vannier and Krause, 2012). On the other
hand, immunocompromised or immunodeficient individuals
can remain seronegative, although they could be carrier of
infectious parasites, in some cases for more than 2 years (Raffalli
and Wormser, 2016). PCR, as a diagnostic test for B. microti
infection, was first described by Persing et al. (1992), which
could detect as little as three merozoites per microliter of blood
(Persing et al., 1992). Since then, method has been improved
greatly. Our laboratory in 2013 developed multiplex PCR method
based on molecular beacons probe for BmTPK amplicon, which
significantly improved specificity and sensitivity of the assay
(Chan et al., 2013) We later also employed this test to examine
human samples from endemic zone for tick-borne diseases
(Akoolo et al., 2017). For majority of human samples, we were
unable to determine time of the start of infection and thus, failed
to determine the stage of infection in patients.
During B. microti infection, different strains of mice display
majority of symptoms noticed in human patients (Vannier et al.,
2004; Coleman et al., 2005; Skariah et al., 2017). Therefore,
the major objective of this study was to examine if B. microti
infection cycle in TLR4 deficient C3H/HeJ mice follows the
same pattern and assess the impact of parasitemia on the
mammalian host pathology and immune response. Our qPCR
result showed very high levels of parasitic DNA in blood of
mice 21 days post infection while examination of blood smears
by microscopy demonstrated barely detectable parasitemia.
A follow-up careful examination of slides indicated that although
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parasitized erythrocytes were not detected readily, released
parasite representing various life stages of B. microti could be
observed, thus explaining our qPCR results. These findings are
similar to culture of B. divergens after growth synchronization
by Cursino-Santos et al. (2016). In vitro culture of B. microti and
B. duncani is not established yet (Skariah et al., 2017). Although
we succeeded inB.microti in vitro culture for some passages when
active parasites were used for infection, parasites in the absence of
ring-forms in RBCs, depicting active B. microti, failed to infect
erythrocytes. However, by reviewing blood smears in available
literature, different life stages of Babesia species could be observed
outside the erythrocytes (Healy and Ruebush, 1980; Shih et al.,
1997; Kjemtrup and Conrad, 2000; Saito-Ito et al., 2000; Vannier
et al., 2008; Sun et al., 2013). These extra-erythrocytic parasites
could be mere remnants of passing parasites or exhibit still active
infection. Infectivity of these parasites was not determined.
Involvement of spleen in resolution of babesiosis in humans is
well established (Vannier et al., 2004; Coleman et al., 2005; Genda
et al., 2016). In our experiments, spleens of all infected mice
were significantly enlarged, likely due to its hyperactivity during
B. microti infection because of increased hematopoietic support
and macrophages activity resulting in erythrophagocytosis
(Homer et al., 2000). In B. microti infected mice, various parasitic
forms were distinguishable even in spleen sections stained with
Hematoxilin-Eosin. Although parasitemia was undetectable by
microscopy at 21 days of infection, detection of B. microti
DNA by our qPCR supports possibility of continuing low-level
infection. Our analysis of white blood cells populations in spleen
at this time point showed that both CD19+ B, and CD3+ T
cell populations were depleted significantly while proportion of
macrophages increased. Despite subversion of splenic adaptive
immune response, mice were able to clear B. microti parasitemia
in blood. Supporting our results, contribution of macrophage
in clearance of B. microti in mice has been noted previously
(Terkawi et al., 2015).
To determine the existence of potentially active infection by
B. microti during apparent convalescent period when certain level
of immune response is maintained, we analyzed concentrations
of plasmatic cytokines. We found higher concentration of
IL-6, IFN-γ, and TNF-α that have been shown to be the
major pro-inflammatory cytokines produced in response to
B. microti infection (Igarashi et al., 1999; Hemmer et al., 2000b).
Increased cytokines production during babesiosis in patients
could be responsible for febrile illness and even myalgia. High
concentrations of IL-4 and IL-10, likely produced by regulatory
B cells, play a major role in disease resolution but could also
indicate still active B. microti infection (Hemmer et al., 2000a;
Jeong et al., 2012). In fact, production of anti-inflammatory IL-
10 in B. microti infected mice was suggested to be important for
survival of the host (Hemmer et al., 2000a). Increase in cytokines
levels agree with our qPCR results that detected parasites in
blood. Thus, inability to detect parasitemia in patients based
upon infected RBCs presence appears to erroneously leave out
infectious but released and free B. microti parasites. Thus, our
studies follow the infection cycle of B. microti and provide
both direct (qPCR and microscopy) and indirect (increase in
the specific plasmatic cytokines) evidence of active infection in
host despite apparent resolution of babesiosis as detected by
parasitemia measurement.
Involvement of CD4 T cells, and IFNγ cytokine has been
shown to confer protective immunity against various protozoan
pathogens during mammalian infection (Favre et al., 1997;
Igarashi et al., 1999; Hemmer et al., 2000a; Hoft et al., 2000;
Wang et al., 2004; McCall and Sauerwein, 2010). Previous
studies showed that although not essential, CD4 T cells and
IFNγ also play important roles in protective immunity against
B. microti infection in mice (Igarashi et al., 1999; Hemmer
et al., 2000a,b; Skariah et al., 2017). Significantly high levels of
IL-2, TNFα, and IFNγ in infected mice could be produced by
activated CD4 helper (Th), primarily Th1 cells potentially in
response to antigens of B. microti they encounter, indicating
that cell mediated immunity is very important for clearance
of the parasites from blood. Previously reported persistence of
B. microti parasitemia in CD4−/−mice supports this hypothesis
(Skariah et al., 2017). Increase in the plasmatic levels of IL-4, IL-5,
and IL-13 produced by Th2 cells was not as significant. These
results suggest relatively less critical role of humoral immunity
in resolution of babesiosis because Th2 cells support stimulation
of antibody production. Interestingly, the levels of IL-6 and IL-
10 cytokines, which are also produced by Th2 cells, were found
to increase significantly and to a much higher levels in the
infected mice. However, IL-6 and IL-10 are also produced by
activated macrophage and B cells also produce IL-10 (Williams
et al., 2000). High levels of IL-10 in serum of B. microti-infected
mice have also been reported previously (Jeong et al., 2012).
Increase of 5–10-fold levels in TNFα production in response to
human Babesia WA1 strain later in infection, suggested to be
produced by CD8+ T cells, and concomitant decrease in IL-10
levels was occurred together with fatal disease in mice (Hemmer
et al., 2000a). We observed resolution of babesiosis caused by
B. microti despite significant increase in plasmatic TNFα level
but it was not as high as reported for WA1 strain, which could
be attributed to simultaneous increased production of IL-10
and its anti-inflammatory activity. IL-10 may also suppresses
overexpression of both IFNγ and TNFα while allowing enough
immune response to build that is sufficient to eradicate B. microti
infection (Trinchieri, 2007; Couper et al., 2008a,b; Redpath et al.,
2014).
Our results further emphasize the importance of macrophage
in immunity against B. microti infection. Significant increase
in IL-6 that promotes differentiation of Th17 cells (McGeachy
et al., 2007) was not found to be associated with downstream
increase in cytokines production by Th17 cells, a unique CD4
cells. Th17 cells produce both IL-17 and IL-21, which are
implicated in various inflammatory responses (Miossec et al.,
2009). Unlike previous studies with Helicobacter pylori where
infection causes adenocarcinoma and produces high levels of IL-
17 and IL-21 (Amedei et al., 2014), only moderate increase in
signature cytokines secreted by Th17 cells, such as IL-17, IL-
17F, IL-21, and IL-22 (Volpe et al., 2008; Korn et al., 2009), was
observed in our experiments. These results suggest that Th17 cells
play only a minor role during B. microti infection and do not
trigger a pronounced inflammatory response, as observed during
Babesia WA1 infection. This is not surprising because Th17 cells
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usually are found to be more important players during diverse
immune-mediated diseases. In summary, our studies confirm the
roles of CD4 cells and macrophage in clearance of parasitized
erythrocytes during B. microti infection and thus, contributing
to resolution of babesiosis (Igarashi et al., 1999, #10007; Hemmer
et al., 2000a,b; Aguilar-Delfin et al., 2003; Skariah et al., 2017).
CONCLUSION
Our studies with patients and mice samples indicate that qPCR
could be effective for detection of both parasitized erythrocytes
as well as free parasites released after lysis of infected RBCs. We
confirm that spleen is important for resolution of babesiosis in
mammalian hosts. Furthermore, increase in pro-inflammatory
plasmatic cytokines, IL-6, IFN-γ, and TNF-α together with the
presence of activated macrophage in both blood and spleen could
help in resolution of infection with B. microti.
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